Notice of investment in Metagen Therapeutics

Notice of investment in Metagen Therapeutics

Keio Innovation Initiative Inc. (KII) has invested in Metagen Therapeutics, which conducts drug discovery and medical services utilizing microbiome science, from a fund operated by the Company.

Please see the press release for details.